[
  {
    "ts": null,
    "headline": "How Recent Developments Are Reshaping the Treace Medical Concepts Investment Story",
    "summary": "Treace Medical Concepts has recently seen its consensus analyst price target decline sharply, dropping from $6.56 to $5.47 per share. This adjustment reflects less optimistic revenue growth projections and a slightly higher discount rate, which signals increased caution about the company’s outlook. Stay tuned to discover how you can keep informed as the narrative around Treace Medical Concepts continues to shift. Analyst Price Targets don't always capture the full story. Head over to our...",
    "url": "https://finnhub.io/api/news?id=18e74cb5eed7504fd2a18d5fe2c6d0461e493243d856187617f43d0d313a284d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763867310,
      "headline": "How Recent Developments Are Reshaping the Treace Medical Concepts Investment Story",
      "id": 137586936,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TFC",
      "source": "Yahoo",
      "summary": "Treace Medical Concepts has recently seen its consensus analyst price target decline sharply, dropping from $6.56 to $5.47 per share. This adjustment reflects less optimistic revenue growth projections and a slightly higher discount rate, which signals increased caution about the company’s outlook. Stay tuned to discover how you can keep informed as the narrative around Treace Medical Concepts continues to shift. Analyst Price Targets don't always capture the full story. Head over to our...",
      "url": "https://finnhub.io/api/news?id=18e74cb5eed7504fd2a18d5fe2c6d0461e493243d856187617f43d0d313a284d"
    }
  }
]